SPARCL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Notably, when examining DOCK4 and SPARCL1 expression in CML patients, we found that both genes were also down-regulated compared to healthy individuals, supporting a potential link between deregulation of hematopoietic stem/progenitor cell expansion and the malignant process.